If you made any changes in Pure these will be visible here soon.

Research Output

2020

Assays for Inducing and Measuring Cell Death to Detect Macrophage Migration Inhibitory Factor (MIF) Release

Zamani, S., Morand, E. F. & Flynn, J. K., 1 Jan 2020, In : Methods in molecular biology (Clifton, N.J.). 2080, p. 173-183 11 p.

Research output: Contribution to journalArticleOtherpeer-review

Connexin-Dependent Transfer of cGAMP to Phagocytes Modulates Antiviral Responses

Pépin, G., De Nardo, D., Rootes, C. L., Ullah, T. R., Al-Asmari, S. S., Balka, K. R., Li, H-M., Quinn, K. M., Moghaddas, F., Chappaz, S., Kile, B. T., Morand, E. F., Masters, S. L., Stewart, C. R., Williams, B. R. G. & Gantier, M. P., 28 Jan 2020, In : mBio. 11, 1, 6 p., e03187-19.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
1 Citation (Scopus)

Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort study

Apostolopoulos, D., Kandane-Rathnayake, R., Louthrenoo, W., Luo, S. F., Jan Wu, Y. J., Lateef, A., Golder, V., Sockalingam, S., Navarra, S. T. V., Zamora, L., Hamijoyo, L., Katsumata, Y., Harigai, M., Chan, M., O'Neill, S., Goldblatt, F., Lau, C. S., Li, Z. G., Hoi, A., Nikpour, M. & 2 others, Morand, E. F. & for the Asia Pacific Lupus Collaboration, Jan 2020, In : The Lancet Rheumatology. 2, 1, p. e24-e30 7 p.

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Plasmacytoid dendritic cells from parent strains of the NZB/W F1 lupus mouse contribute different characteristics to autoimmune propensity

Zhan, Y., Kong, I., Chopin, M., Macri, C., Zhang, J. G., Xie, J., Nutt, S. L., O'Keeffe, M., Hawkins, E. D., Morand, E. F. & Lew, A. M., Mar 2020, In : Immunology and Cell Biology. 98, 3, p. 203-214 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Trial of Anifrolumab in Active Systemic Lupus Erythematosus

Morand, E. F., Furie, R., Tanaka, Y., Bruce, I. N., Askanase, A. D., Richez, C., Bae, S. C., Brohawn, P. Z., Pineda, L., Berglind, A., Tummala, R. & for the TULIP-2 Trial Investigators, 16 Jan 2020, In : The New England Journal of Medicine. 382, 3, p. 211-221 11 p.

Research output: Contribution to journalArticleResearchpeer-review

20 Citations (Scopus)

Analysis of serum interleukin(IL)-1α, IL-1β and IL-18 in patients with systemic sclerosis

Lin, E., Vincent, F. B., Sahhar, J., Ngian, G-S., Kandane-Rathnayake, R., Mende, R., Morand, E. F., Lang, T. & Harris, J., 1 Jan 2019, In : Clinical & Translational Immunology. 8, 4, 11 p., e1045.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
1 Citation (Scopus)

A potential association between IL-3 and type I and III interferons in systemic lupus erythematosus

Oon, S., Monaghan, K., Ng, M., Hoi, A., Morand, E., Vairo, G., Maraskovsky, E., Nash, A. D., Wicks, I. P. & Wilson, N. J., 24 Dec 2019, In : Clinical & Translational Immunology. 8, 12, 8 p., e01097.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Attainment of the lupus low disease activity state is associated with protection from damage accrual in patients with active disease at baseline

Golder, V., Morand, E. F., Kandane-Rathnayake, R., Huq, M., Nim, H., Louthrenoo, W., Luo, S. F., Wu, Y-J., Lateef, A., Sockalingam, S., Navarra, S. T. V., Zamora, L., Hamijoyo, L., Katsumata, Y., Harigai, M., Chan, M., O’Neill, S., Goldblatt, F., Sing Lau, C., Li, Z. & 2 others, Hoi, A. & Nikpour, M., 2019, p. 203-203. 1 p.

Research output: Contribution to conferenceAbstract

Comparison of effects of DORIS remission and lupus low disease activity state (LLDAS) on disease outcomes in a multinational prospective study

Morand, E., Golder, V., Kandane-Rathnayake, R., Huq, M., Nim, H., Louthrenoo, W., Luo, S. F., Lateef, A., Sockalingam, S., Navarra, S., Hamijoyo, L., Katsumata, Y., Chan, M., Hoi, A. & Nikpour, M., 2019. 1 p.

Research output: Contribution to conferenceAbstract

Could GILZ be the answer to glucocorticoid toxicity in lupus?

Flynn, J. K., Dankers, W. & Morand, E. F., 17 Jul 2019, In : Frontiers in Immunology. 10, JULY, 13 p., 1684.

Research output: Contribution to journalReview ArticleResearchpeer-review

Open Access
File

Defining remission in systemic lupus erythematosus: still elusive?

Morand, E. F. & Golder, V., Nov 2019, In : The Lancet Rheumatology. 1, 3, p. e137-e138

Research output: Contribution to journalComment / DebateOtherpeer-review

Development of the Asia Pacific Lupus Collaboration cohort

Kandane-Rathnayake, R., Golder, V., Louthrenoo, W., Luo, S. F., Jan Wu, Y. J., Li, Z., An, Y., Lateef, A., Sockalingam, S., Navarra, S. V., Zamora, L., Hamijoyo, L., Katsumata, Y., Harigai, M., Chan, M., O’Neill, S., Goldblatt, F., Hao, Y., Zhang, Z., Al-Saleh, J. & 8 others, Khamashta, M., Takeuchi, T., Tanaka, Y., Bae, S. C., Sing Lau, C., Hoi, A., Nikpour, M. & Morand, E. F., 1 Mar 2019, In : International Journal of Rheumatic Diseases. 22, 3, p. 425-433 9 p.

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)

Effect of storage duration on cytokine stability in human serum and plasma

Vincent, F. B., Nim, H. T., Lee, J. P. W., Morand, E. F. & Harris, J., Jan 2019, In : Cytokine. 113, p. 453-457 5 p.

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)

Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort study

Golder, V., Kandane-Rathnayake, R., Huq, M., Louthrenoo, W., Luo, S. F., Jan Wu, Y. J., Lateef, A., Sockalingam, S., Navarra, S. T. V., Zamora, L., Hamijoyo, L., Katsumata, Y., Harigai, M., Chan, M., O'Neill, S., Goldblatt, F., Lau, C. S., Li, Z. G., Hoi, A., Nikpour, M. & 2 others, Morand, E. F. & for the Asia Pacific Lupus Collaboration, Oct 2019, In : The Lancet Rheumatology. 1, 2, p. e103-e110 8 p.

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)

Global consensus building and prioritisation of fundamental lupus challenges: The ALPHA project

Manzi, S., Raymond, S., Tse, K., Peña, Y., Anderson, A., Arntsen, K., Bae, S. C., Bruce, I., Dörner, T., Getz, K., Hanrahan, L., Kao, A., Morand, E., Rovin, B., Schanberg, L. E., Von Feldt, J. M., Werth, V. P. & Costenbader, K., 1 Jul 2019, In : Lupus Science and Medicine. 6, 1, 7 p., e000342.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Longitudinal associations of active renal disease with irreversible organ damage accrual in systemic lupus erythematosus

Kandane-Rathnayake, R., Kent, J. R., Louthrenoo, W., Luo, S. F., Wu, Y. J. J., Lateef, A., Golder, V., Sockalingam, S., Navarra, S. A., Zamora, L., Hamijoyo, L., Katsumata, Y., Harigai, M., Chan, M., O’Neill, S., Goldblatt, F., Lau, C. S., Hoi, A., Nikpour, M. & Morand, E., 1 Dec 2019, In : Lupus. 28, 14, p. 1669-1677 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Lupus Low Disease Activity State (LLDAS) discriminates responders in the BLISS-52 and BLISS-76 phase III trials of belimumab in systemic lupus erythematosus

Oon, S., Huq, M., Golder, V., Ong, P. X., Morand, E. F. & Nikpour, M., 1 May 2019, In : Annals of the Rheumatic Diseases. 78, 5, p. 29-633 5 p.

Research output: Contribution to journalArticleResearchpeer-review

13 Citations (Scopus)

Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study

Golder, V., Kandane-Rathnayake, R., Huq, M., Nim, H. T., Louthrenoo, W., Luo, S. F., Jan Wu, Y. J., Lateef, A., Sockalingam, S., Navarra, S. T. V., Zamora, L., Hamijoyo, L., Katsumata, Y., Harigai, M., Chan, M., O'Neill, S., Goldblatt, F., Sing Lau, C., Li, Z. G., Hoi, A. & 3 others, Nikpour, M., Morand, E. F. & for the Asia Pacific Lupus Collaboration, Oct 2019, In : The Lancet Rheumatology. 1, 2, p. e95-e102 8 p.

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)

Lupus Low Disease Activity State is Associated with Reduced Direct Healthcare Costs in Patients with Systemic Lupus Erythematosus

Yeo, A. L., Koelmeyer, R., Kandane-Rathnayake, R., Golder, V., Hoi, A., Huq, M., Hammond, E., Nab, H., Nikpour, M. & Morand, E. F., 8 Jul 2019, (Accepted/In press) In : Arthritis Care & Research. 19 p.

Research output: Contribution to journalArticleResearchpeer-review

Machine learning applied to whole-blood RNA-sequencing data uncovers distinct subsets of patients with systemic lupus erythematosus

Figgett, W. A., Monaghan, K., Ng, M., Alhamdoosh, M., Maraskovsky, E., Wilson, N. J., Hoi, A. Y., Morand, E. F. & Mackay, F., 12 Dec 2019, In : Clinical & Translational Immunology. 8, 12, 15 p., e01093.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Outcomes of patients admitted to hospital medical units with back pain

Kyi, L., Kandane-Rathnayake, R., Morand, E. & Roberts, L., 1 Mar 2019, In : Internal Medicine Journal. 49, 3, p. 316-322 7 p.

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)

Prospective multicenter validation of the lupus low disease activity state (LLDAS) treatment target

Morand, E., Golder, V., Kandane-Rathnayake, R., Huq, M., Nim, H., Louthrenoo, W., Luo, S. F., Lateef, A., Sockalingam, S., Navarra, S., Hamijoyo, L., Katsumata, Y., Chan, M., Hoi, A. & Nikpour, M., 2019, p. 25. 1 p.

Research output: Contribution to conferenceAbstract

Rare variants in non-coding regulatory regions of the genome that affect gene expression in systemic lupus erythematosus

Jones, S. A., Cantsilieris, S., Fan, H., Cheng, Q., Russ, B. E., Tucker, E. J., Harris, J., Rudloff, I., Nold, M., Northcott, M., Dankers, W., Toh, A. E. J., White, S. J. & Morand, E. F., 1 Dec 2019, In : Scientific Reports. 9, 1, 9 p., 15433.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Rediscovering MIF: New Tricks for an Old Cytokine

Harris, J., VanPatten, S., Deen, N. S., Al-Abed, Y. & Morand, E. F., 1 May 2019, In : Trends in Immunology. 40, 5, p. 447-462 16 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

8 Citations (Scopus)

Serum and urinary macrophage migration inhibitory factor (MIF) in primary Sjögren's syndrome

Vincent, F. B., Lang, T., Kandane-Rathnayake, R. K., Downie-Doyle, S., Morand, E. F. & Rischmueller, M., 1 May 2019, In : Joint Bone Spine. 86, 3, p. 393-395 3 p.

Research output: Contribution to journalLetterOtherpeer-review

2 Citations (Scopus)

Serum soluble Fas and Fas ligand (FasL) in primary Sjögren's syndrome

Vincent, F. B., Bubicich, M., Downie-Doyle, S., Mackay, F., Morand, E. F. & Rischmueller, M., 1 May 2019, In : Clinical and Experimental Rheumatology. 37, 3, p. 254-256 3 p.

Research output: Contribution to journalLetterOtherpeer-review

Serum soluble Fas and Fas ligand (FasL) in primary Sjögren’s syndrome

Vincent, F. B., Bubicich, M., Downie-Doyle, S., Mackay-Fisson, F., Morand, E. F. & Rischmueller, M., 2019, In : Clinical and Experimental Rheumatology. 37, 118, p. S254-S256 3 p.

Research output: Contribution to journalLetterResearchpeer-review

Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity

Yang, H., Xia, L., Chen, J., Zhang, S., Martin, V., Li, Q., Lin, S., Chen, J., Calmette, J., Lu, M., Fu, L., Yang, J., Pan, Z., Yu, K., He, J., Morand, E., Schlecht-Louf, G., Krzysiek, R., Zitvogel, L., Kang, B. & 7 others, Zhang, Z., Leader, A., Zhou, P., Lanfumey, L., Shi, M., Kroemer, G. & Ma, Y., 1 Sep 2019, In : Nature Medicine. 25, 9, p. 1428-1441 14 p.

Research output: Contribution to journalArticleResearchpeer-review

7 Citations (Scopus)

Therapeutic trajectories following high disease activity state in SLE

McMaster, C., Nim, H., Koelmeyer, R., Frauman, A., Morand, E. & Hoi, A. Y., 2019. 1 p.

Research output: Contribution to conferenceAbstract

Treat-to-target Endpoint Definitions in Systemic Lupus Erythematosus: More is less?

Morand, E. F. & Golder, V., Oct 2019, In : The Journal of Rheumatology. 46, 10, p. 1256-1258 3 p.

Research output: Contribution to journalEditorialOtherpeer-review

Open Access

Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial

Furie, R. A., Morand, E. F., Bruce, I. N., Manzi, S., Kalunian, K. C., Vital, E. M., Lawrence Ford, T., Gupta, R., Hiepe, F., Santiago, M., Brohawn, P. Z., Berglind, A., Tummala, R. & on behalf of the TULIP-1 study investigators, Dec 2019, In : The Lancet Rheumatology. 1, 4, p. e208-e219 12 p.

Research output: Contribution to journalArticleResearchpeer-review

11 Citations (Scopus)
2018

Acceptability of opt-out consent in a hospital patient population

Boulos, D., Morand, E., Foo, M., Trivedi, J. D., Lai, R., Huntersmith, R., Zhang, K., Stark, C. B. & Le, S., 1 Jan 2018, In : Internal Medicine Journal. 48, 1, p. 84-87 4 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
4 Citations (Scopus)

Analysis of serum interleukin (IL)-1β and IL-18 in systemic lupus erythematosus

Mende, R., Vincent, F. B., Kandane-Rathnayake, R., Koelmeyer, R., Lin, E., Chang, J., Hoi, A., Morand, E. F., Harris, J. & Lang, T., 7 Jun 2018, In : Frontiers in Immunology. 9, JUN, 10 p., 1250.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
18 Citations (Scopus)
Open Access
File
3 Citations (Scopus)

Analysis of urinary macrophage migration inhibitory factor in systemic lupus erythematosus

Vincent, F. B., Slavin, L., Hoi, A. Y., Kitching, A. R., Mackay, F., Harris, J., Kandane-Rathnayake, R. & Morand, E. F., 1 Jan 2018, In : Lupus Science and Medicine. 5, 1, 10 p., e000277.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
2 Citations (Scopus)

Association between sledai-2k domains and organ damage accrual

Zhang, K., Boyd, S., Petitjean, F., Hoi, A., Koelmeyer, R., Morand, E. & Nim, H., 2018. 1 p.

Research output: Contribution to conferenceAbstract

Author Correction: Endogenous Annexin-A1 Regulates Haematopoietic Stem Cell Mobilisation and Inflammatory Response Post Myocardial Infarction in Mice In Vivo

Qin, C. X., Finlayson, S. B., Al-Sharea, A., Tate, M., De Blasio, M. J., Deo, M., Rosli, S., Prakoso, D., Thomas, C. J., Kiriazis, H., Gould, E., Yang, Y. H., Morand, E. F., Perretti, M., Murphy, A. J., Du, X. J., Gao, X. M. & Ritchie, R. H., 2 May 2018, In : Scientific Reports. 8, 1, p. 7185-7185 1 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

Open Access

Discordance of patient and physician health status concerns in systemic lupus erythematosus

Golder, V., Ooi, JJY., Antony, A. S., Ko, T., Morton, S., Kandane-Rathnayake, R., Morand, EF. & Hoi, A. Y., 1 Mar 2018, In : Lupus. 27, 3, p. 501-506 6 p.

Research output: Contribution to journalArticleResearchpeer-review

9 Citations (Scopus)

Formyl peptide receptor activation inhibits the expansion of effector T cells and synovial fibroblasts and attenuates joint injury in models of rheumatoid arthritis

Odobasic, D., Jia, Y., Kao, W., Fan, H., Wei, X., Gu, R., Ngo, D., Richard Kitching, A., Holdsworth, S. R., Morand, E. F. & Yang, Y. H., 1 Aug 2018, In : International Immunopharmacology. 61, p. 140-149 10 p.

Research output: Contribution to journalArticleResearchpeer-review

6 Citations (Scopus)

Genetic contributions to lupus nephritis in a multi-ethnic cohort of systemic lupus erythematous patients

Lanata, C. M., Nititham, J., Taylor, K. E., Chung, S. A., Torgerson, D. G., Seldin, M. F., Pons-Estel, B. A., Tusié-Luna, T., Tsao, B. P., Morand, E. F., Alarcón-Riquelme, M. E. & Criswell, L. A., 1 Jun 2018, In : PLoS ONE. 13, 6, 15 p., e0199003.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
8 Citations (Scopus)

Gilz-activin a as a novel signaling axis orchestrating mesenchymal stem cell and Th17 cell interplay

Luz-Crawford, P., Espinosa-Carrasco, G., Ipseiz, N., Contreras, R., Tejedor, G., Medina, D. A., Vega-Letter, A. M., Ngo, D., Morand, E. F., Pène, J., Hernandez, J., Jorgensen, C. & Djouad, F., 1 Jan 2018, In : Theranostics. 8, 3, p. 846-859 14 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
3 Citations (Scopus)

GILZ-dependent modulation of mTORC1 regulates spermatogonial maintenance

La, H. M., Chan, A-L., Legrand, J. M. D., Rossello, F. J., Gangemi, C. G., Papa, A., Cheng, Q., Morand, E. F. & Hobbs, R. M., 1 Sep 2018, In : Development (Cambridge). 145, 18, dev165324.

Research output: Contribution to journalArticleResearchpeer-review

6 Citations (Scopus)

Identification of a novel autoantibody against self-vimentin specific in secondary Sjögren's syndrome

Li, Y. H., Gao, Y. P., Dong, J., Shi, L. J., Sun, X. L., Li, R., Zhang, X. W., Liu, Y., Long, L., He, J., Zhong, Q. J., Morand, E., Yang, G. & Li, Z. G., 12 Feb 2018, In : Arthritis Research & Therapy. 20, 1, 8 p., 30.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
4 Citations (Scopus)

Longitudinal association of type 1 interferon-induced chemokines with disease activity in systemic lupus erythematosus

Connelly, K. L., Kandane-Rathnayake, R., Huq, M., Hoi, A., Nikpour, M. & Morand, E. F., 1 Dec 2018, In : Scientific Reports. 8, 1, 9 p., 3268.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
4 Citations (Scopus)

Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: Post-hoc analysis of the Phase IIb MUSE trial of anifrolumab

Morand, E. F., Trasieva, T., Berglind, A., Illei, G. G. & Tummala, R., 1 May 2018, In : Annals of the Rheumatic Diseases. 77, 5, p. 706-713 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
21 Citations (Scopus)

Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation

Lang, T., Lee, J. P. W., Elgass, K., Pinar, A. A., Tate, M. D., Aitken, E. H., Fan, H., Creed, S. J., Deen, N. S., Traore, D. A. K., Mueller, I., Stanisic, D., Baiwog, F. S., Skene, C., Wilce, M. C. J., Mansell, A., Morand, E. F. & Harris, J., 1 Dec 2018, In : Nature Communications. 9, 1, 15 p., 2223.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
29 Citations (Scopus)